Avion Wealth’s Ginkgo Bioworks DNA Stock Holding History

Avion Wealth’s Portfolio DNA Stock Details DNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-53	Closed	–	–	1269
2025 Q1	$0	Buy	+53	New	+$540	﹤0.01%	1098
2024 Q3	–	Sell	-20	Closed	–	–	1084
2024 Q2	$0	Buy	+20	New	+$597	﹤0.01%	995
2024 Q1	–	Sell	-10	Closed	-$1K	–	1171
2023 Q4	$1K	Sell	10 -10	-50%	-$612	﹤0.01%	754
2023 Q3	$0	Hold	20	–	–	﹤0.01%	890
2023 Q2	$0	Buy	+20	New	+$1.18K	﹤0.01%	784

Other funds holding DNA

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

ACG

Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Avion Wealth's DNA Position: Q2 2025 in Review

Avion Wealth sold out of Ginkgo Bioworks (DNA) in Q2 2025, closing a stake of 53 shares.

Avion Wealth first reported a position in DNA in Q2 2023 and held it in 5 quarters. The position peaked at $1K in Q4 2023. 166 funds tracked by Wall St. Rank hold DNA as of Q2 2025.

Avion Wealth reported no remaining Ginkgo Bioworks position as of Q2 2025 after selling out during the quarter.
Avion Wealth sold 53 Ginkgo Bioworks shares in Q2 2025.
Avion Wealth first reported a position in Ginkgo Bioworks in Q2 2023 and held it in 5 quarters.
Avion Wealth's Ginkgo Bioworks position peaked at $1K in Q4 2023.
166 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2025.

Based on Avion Wealth's 13F filing for Q2 2025, filed 25 Jul 2025.